Nexgel, Inc. revenue
Nexgel, Inc.'s revenue was $11.4m in fiscal 2025, up 31.5% on the year before. Since fiscal 2018 ($2.2m) it has grown at a compound 26.4% a year. Over the last twelve months it was $12.1m.
Revenue history
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 1 | 1 | 2 | 2 | 4 | 9 | 11 | 12 |
| Growth on the year before | — | −67.6% | −6.0% | +130.1% | +32.0% | +99.7% | +112.5% | +31.5% | — |
| Gross profit | 1 | −0 | −0 | 0 | 0 | 0 | 3 | 5 | 4 |
| Gross margin | 23.2% | −19.1% | −43.2% | 0.5% | 12.5% | 9.1% | 31.6% | 39.5% | 35.1% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Nexgel, Inc. | $12.1m | 3.4% | 61.2% |
| Sintx Technologies, Inc. | $1.3m | -28.5% | -15.9% |
| Orasure Technologies Inc | $112m | -18.9% | -38.4% |
| Mimedx Group, Inc. | $304m | -22.8% | -0.6% |
| Organogenesis Holdings Inc. | $457m | 6.5% | 0.0% |
| UFP Technologies Inc | $632m | 7.3% | 17.8% |
Compare with peers
- Sintx Technologies, Inc. revenue
- Orasure Technologies Inc revenue
- Mimedx Group, Inc. revenue
- Organogenesis Holdings Inc. revenue
- UFP Technologies Inc revenue
Head to head: NXGL vs SINTNXGL vs OSURMDXG vs NXGL
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies